ZALEPLON
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 151319-34-5 |
|---|---|
| INCI Name | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide |
| PubChem CID | 5719 |
| Molecular Formula | C17H15N5O |
| InChIKey | InChI=1S/C17H15N5O/c1-3-21( |
| SMILES | CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C |
Known Aliases (24)
Common Name
3'-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)-N-ETHYLACETANILIDE
ACETAMIDE, N-(3-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)PHENYL)-N-ETHYL-
CL 284,846
CL-284846
L-846
L846
LJC-10846
LJC10846
SKP-1041
SONATA
ZAL-846
ZALEPLON CIV
ZALEPLON CIV [USP-RS]
ZALEPLON [EMA EPAR]
zaleplon [INN]
ZALEPLON [JAN]
ZALEPLON [MART.]
ZALEPLON [MI]
ZALEPLON [ORANGE BOOK]
ZALEPLON [USAN]
ZALEPLON [USP MONOGRAPH]
ZALEPLON [VANDF]
Zaleplon [WHO-DD]
ZERENE
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | S62U433RMH |
ZALEPLON |
CAS: 151319-34-5 INN: 7312 MESH: C085665 USAN: GG-36 CHEBI: 10102 EVMPD: SUB00132MIG RXCUI: 74667 ChEMBL: CHEMBL1521 IUPHAR: 4345 NDF-RT: N0000183360 SMS_ID: 100000088001 DEA NO.: 2781 LACTMED: Zaleplon PUBCHEM: 5719 WHO-ATC: N05CF03 DAILYMED: S62U433RMH FDA UNII: S62U433RMH LIVERTOX: NBK548924 WHO-VATC: QN05CF03 DRUG BANK: DB00962 WIKIPEDIA: ZALEPLON EPA CompTox: DTXSID5023748 MERCK INDEX: m11579 RS_ITEM_NUM: 1724350 DRUG CENTRAL: 2857 NCI_THESAURUS: C29756 EMA ASSESSMENT REPORTS: ZERENE (WITHDRAWN: SLEEP INITIATION AND MAINTENANCE DISORDERS) |
Record Info
| ID | 5y8KmFZ8KfvYQJhZoc56Wv |
|---|---|
| Created | April 10, 2026, 7:48 p.m. |
| Modified | April 11, 2026, 12:17 a.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |